Duramorph

This page contains recent news articles, when available, and an overview of Duramorph but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Duramorph
(when available)

Pharmacology and use:
Morphine is a narcotic pain management agent indicated for the relief of pain in patients who require opioid analgesics for more than a few days. Morphine interacts predominantly with the opioid mu-receptor. These mu-binding sites are discretely distributed in the human brain, with high densities in the posterior amygdala, hypothalamus, thalamus, nucleus caudatus, putamen, and certain cortical areas. They are also found on the terminal axons of primary afferents within laminae I and II (substantia gelatinosa) of the spinal cord and in the spinal nucleus of the trigeminal nerve. In clinical settings, Morphine exerts its principal pharmacological effect on the central nervous system and gastrointestinal tract. Its primary actions of therapeutic value are analgesia and sedation. Morphine appears to increase the patient's tolerance for pain and to decrease discomfort, although the presence of the pain itself may still be recognized. In addition to analgesia, alterations in mood, euphoria and dysphoria, and drowsiness commonly occur. Opioids also produce respiratory depression by direct action on brain stem respiratory centers. For the relief and treatment of severe pain

Mechanism Of Action:
The precise mechanism of the analgesic action is unknown. However, specific CNS opiate receptors have been identified and likely play a role in the expression of analgesic effects. The mechanism of respiratory depression involves a reduction in the responsiveness of the brain stem respiratory centers to increases in carbon dioxide tension and to electrical stimulation.

News Articles on Morphine

FDA Safety Labeling Changes: Activella, Duramorph PF, Nutropin  -  Sep 7, 2005
Sept. 7, 2005 — The US Food and Drug Administration (FDA) approved in June revisions to safety labeling to advise that use of estradiol/norethindrone ... Medscape

Cut-off and toxicity levels for drugs-of-abuse testing.(Table)  -  Aug 1, 2007
2000 ng/mL (as >200 ng/mL morphine) Morphine (Duramorph) 2000 ng/mL >200 ng/mL ... None detected Morphine (Duramorph) 65-80 ng/mL Methadone (Dolophine, ... Free with registration - Medical Laboratory Observer - AccessMyLibrary.com

Cut-off and toxicity levels for drugs-of-abuse testing.(Chart)  -  Aug 1, 2006
Morpho, 2 days (Duramorph) White stuff Methadone Methadose 3 days (Dolophine, ... Morphine 65-80 ng/mL (Duramorph) Methadone For narcotic (Dolophine, ... Free with registration - Medical Laboratory Observer - AccessMyLibrary.com

Cut-off and toxicity levels for drugs-of-abuse testing.(Table)  -  Aug 1, 2007
...trade name) Blood reference (therapeutic) range OPIATES Heroin (Diacetylmorphine) None detected Morphine (Duramorph) 65-80 ng/mL Methadone (Dolophine, ... $4.95 - Medical Laboratory Observer - ECNext

Cut-off and toxicity levels for drugs-of-abuse testing.(Chart)  -  Aug 1, 2006
Morpho, 2 days (Duramorph) White stuff Methadone Methadose 3 days (Dolophine, ... Morphine 65-80 ng/mL (Duramorph) Methadone For narcotic (Dolophine, ... $4.95 - Medical Laboratory Observer - ECNext

Texas Case Law - RENAISSANCE SURG. v. JIMENEZ, 13-07-121-CV ( …  -  Aug 28, 2008
As part of the surgery, Jimenez required anesthesia, including epidural Duramorph. The manufacturer's warning states that after receiving Duramorph, ... Pay-Per-View - Texas Case Law - Loislaw

FDA staff cite abuse concern with Embeda  -  Nov 12, 2008
WASHINGTON (Reuters) - Alpharma Inc's powerful painkiller Embeda, which contains morphine sulfate and Duramorph, may not thwart drug abusers despite design ... Reuters

Would you suspect this skin-eating infection? This potentially fatal...  -  Mar 1, 2006
Patients may require an opiate analgesic, such as morphine (Duramorph, Roxanol, others), or fentanyl (Actiq, Sublimaze) before you change the wound dressing ... Pay-Per-View - RN - Factiva, from Dow Jones

A Teenage Trauma Tale  -  Aug 15, 2007
Medications at the time of hospital admission include: morphine (Duramorph), 3.5 mg administered intravenously every 2 hours as need for pain, ... Medscape

6 Considerations for Successful Outpatient Knee Replacement  -  Apr 28, 2008
...“There are a lot of papers out there that recommend a spinal block and Duramorph, which is slowly absorbed, along with general anesthesia. ... Becker's ASC Review

Epidural analgesia.(Clinical 'How To')  -  Aug 1, 2005
The most common epidural opioids include a morphine derivative (Duramorph[R]) and fentanyl citrate (Sublimaze[R]). Bupivacaine (Marcaine[R]), a local ... $4.95 - MedSurg Nursing - ECNext

Preoperative pain management protocol may reduce arthrofibrosis in …  -  Jun 18, 2007
The perioperative pain cocktail included: Xylocaine [lidocaine, AstraZeneca], Toradol [ketorolac, Roche], Duramorph [morphine injection, Baxter Healthcare] ... Ortho SuperSite

Oral analgesics for acute nonspecific pain.  -  Mar 1, 2005
No substantial evidence supports the notion that any other narcotic has greater efficacy or fewer side effects than morphine (Duramorph). ... Pay-Per-View - American Family Physician - Factiva, from Dow Jones

Care of the breastfeeding mother in medical-surgical areas.(Clinical ...  -  Apr 1, 2007
...methadone (Dolophine[R]), morphine (Duramorph[R], Infumorph[R]), naproxen (Anaprox[R], Naprosyn[R], Aleve[R]), and secobarbital (Seconal[R]). ... Free with registration - MedSurg Nursing - AccessMyLibrary.com

Oral analgesics for acute nonspecific pain.  -  Mar 1, 2005
No substantial evidence supports the notion that any other narcotic has greater efficacy or fewer side effects than morphine (Duramorph). ... $4.95 - American Family Physician - ECNext

Columbus Ledger-Enquirer : PRESCRIPTION DRUGS BY SCHEDULE  -  Oct 23, 2007
Morphine (MS Contin, Oramorph, Duramorph, Roxanol). > Oxycodone (OxyContin, Percodan, Percocet, Tylox, Roxicodone). > Oxymorphone (Numorphan) ... $2.95 - Ledger-Enquirer - NewsBank

Columbus Ledger-Enquirer : THREE MOST-ABUSED TYPES OF …  -  Oct 21, 2007
Morphine (MS Contin, Oramorph, Duramorph, Roxanol). > Oxycodone (OxyContin, Percodan, Percocet, Tylox, Roxicodone). > Oxymorphone (Numorphan) ... $2.95 - Ledger-Enquirer - NewsBank

Columbus Ledger-Enquirer : THREE MOST-ABUSED TYPES OF …  -  Oct 21, 2007
Morphine (MS Contin, Oramorph, Duramorph, Roxanol). > Oxycodone (OxyContin, Percodan, Percocet, Tylox, Roxicodone). > Oxymorphone (Numorphan) ... $2.95 - Ledger-Enquirer - NewsBank

Opioid analgesia during evaluation of acute abdominal pain.(Cochrane ...  -  Oct 1, 2007
Most of the trials compared 5 to 15 mg of morphine (Duramorph) with an equivalent amount of saline. There were no significant differences between groups in ... $4.95 - American Family Physician - ECNext

Drug dosing adjustments in patients with chronic kidney disease.(Drug...  -  May 15, 2007
Metabolites of meperidine (Demerol), dextropropoxyphene (propoxyphene [Darvon]), morphine (Duramorph), tramadol (Ultram), and codeine can accumulate in ... $4.95 - American Family Physician - ECNext

Brand Names/Synonyms:
Duramorph is also known by the following brand names and/or synonymsAVINZA; Apokyn; Astramorph Pf; Avinza; Depodur; Diacetylmorphine Hydrochloride; Diamorphine Hydrochloride; Dulcontin; Duramorph; Duramorph Pf; Duromorph; Epimorph; Heroin Hydrochloride; Heroine Hydrochloride; Kadian; L-Morphine; M S Contin; M-Eslon; M.O.S; M.O.S.-S.R; MS IR; MS.IR; MS/L; MS/S; MSIR; Meconium; Morfina; Morphia; Morphin; Morphina; Morphine; Morphine Extra-Forte; Morphine Forte; Morphine H.P; Morphine Sulfate; Morphinism; Morphinum; Morphitec; Morphium; Moscontin; Ms Contin; Ms/L Concentrate; Nepenthe; O,O'-Diacetylmorphine Hydrochloride; Oms Concentrate; Oramorph Sr; Ospalivina; Rescudose; Rms Uniserts; Roxanol; Roxanol 100; Roxanol Ud; Statex; Statex Drops

Drug Category:
Duramorph is categorized under the following by the FDA: Narcotics; Analgesics; Opiate Agonists; ATC:G04BE07; ATC:N02AA01; ATC:N02AA04; ATC:N02AA09; ATC:N04BC07; ATC:R05DA01; ATC:R05DA05; ATC:S01XA06

Dosage Forms:
CAPSULE (SUSTAINED-RELEASE); DROPS; LIQUID; SOLUTION; SUPPOSITORY; SUPPOSITORY (SUSTAINED-RELEASE); SYRUP; TABLET; TABLET (EXTENDED-RELEASE); TINCTURE

Absorption:
Bioavailability is ~30%

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
(5α,6α)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy